Ticker > Company >

Prevest Denpro share price

Prevest Denpro Ltd.

BSE: 543363 SECTOR: Medical Equipment/Supplies/Accessories  43k   318   9

540.25
0 0
BSE: Today, 09:33 AM

Price Summary

Today's High

₹ 540.25

Today's Low

₹ 540.25

52 Week High

₹ 673

52 Week Low

₹ 332

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

648.46 Cr.

Enterprise Value

600.03 Cr.

No. of Shares

1.2 Cr.

P/E

38.63

P/B

6.76

Face Value

₹ 10

Div. Yield

0.19 %

Book Value (TTM)

₹  79.89

CASH

48.43 Cr.

DEBT

0 Cr.

Promoter Holding

73.6 %

EPS (TTM)

₹  13.99

Sales Growth

13.21%

ROE

19.98 %

ROCE

26.8%

Profit Growth

2.63 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.21%
3 Year25.61%
5 Year23.97%

Profit Growth

1 Year2.63%
3 Year30.79%
5 Year40.04%

ROE%

1 Year19.98%
3 Year24.41%
5 Year30.1%

ROCE %

1 Year26.8%
3 Year32.9%
5 Year38.26%

Debt/Equity

0

Price to Cash Flow

56.43

Interest Cover Ratio

102.2511

CFO/PAT (5 Yr. Avg.)

0.761710237692833

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 73.60 0.00
Jun 2024 73.60 0.00
Mar 2024 73.60 0.00
Dec 2023 73.60 0.00
Sep 2023 73.60 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.7904663918136% for the Past 3 years.
  • The company has shown a good revenue growth of 25.6129756058377% for the Past 3 years.
  • Company has been maintaining healthy ROE of 24.4145999096964% over the past 3 years.
  • Company has been maintaining healthy ROCE of 32.8983442566145% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 102.2511.
  • The Company has been maintaining an effective average operating margins of 33.0715062968197% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 38.0732 days.
  • Company has a healthy liquidity position with current ratio of 12.3149.
  • The company has a high promoter holding of 73.6%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 13.18 13.62 16.25 13.34 16.26
Total Expenditure 8.67 9.15 10.36 8.86 10.44
Operating Profit 4.51 4.47 5.88 4.49 5.81
Other Income 0.74 0.68 0.84 0.86 1.07
Interest 0 0 0 0 0
Depreciation 0.22 0.42 0.46 0.48 0.47
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.03 4.73 6.26 4.88 6.41
Tax 1.28 1.1 1.6 1.22 1.57
Profit After Tax 3.74 3.63 4.66 3.65 4.84
Adjusted EPS (Rs) 3.12 3.03 3.89 3.04 4.03

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 22.77 28.48 38.11 49.85 56.44
Total Expenditure 17.58 19.45 22.89 30.05 36.4
Operating Profit 5.19 9.02 15.22 19.81 20.04
Other Income 1.79 1.04 1.62 2.03 2.86
Interest 0.26 0.25 0.27 0.21 0.21
Depreciation 0.44 0.47 0.52 0.68 1.28
Exceptional Items 0 0 0 0 0
Profit Before Tax 6.28 9.34 16.05 20.96 21.41
Tax 1.27 2.13 4.48 5.25 5.29
Net Profit 5.01 7.21 11.57 15.71 16.12
Adjusted EPS (Rs.) 5.67 8.16 9.64 13.09 13.43

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.29 0.29 12 12 12
Total Reserves 15.02 22.21 45.08 60.79 76.6
Borrowings 1.59 1.39 1.37 0 0
Other N/C liabilities 0.36 0.24 0.29 0.37 0.69
Current liabilities 3.82 6.55 5.4 5.44 5.52
Total Liabilities 21.08 30.68 64.14 78.61 94.81
Assets
Net Block 5.2 5.36 6.72 7.41 26.75
Capital WIP 0.11 1.71 4.72 16.89 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0.05
Loans & Advances 0.19 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 15.58 23.6 52.7 54.32 68.02
Total Assets 21.08 30.68 64.14 78.61 94.81
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 6.28 9.34 16.05 20.96 21.41
Adjustment 0.21 0.15 -0.6 -0.94 -1.22
Changes in Assets & Liabilities -0.52 1.17 -4.06 -4.42 -4.08
Tax Paid -1.24 -1.9 -4.43 -5.16 -4.62
Operating Cash Flow 4.73 8.76 6.96 10.43 11.49
Investing Cash Flow -0.52 -1.93 -3.87 -12.38 -1.75
Financing Cash Flow 0.03 -0.57 22.82 -1.37 -0.32
Net Cash Flow 4.24 6.26 25.91 -3.32 9.42

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 73.60 73.60 73.60 73.60 73.60
alka beotra 0.03 0.03 0.03 0.03 0.03
atul modi 37.52 37.52 37.52 37.52 37.52
namrata modi 36.03 36.03 36.03 36.03 36.03
niharika modi 0.03 0.03 0.03 0.03 0.03
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 26.40 26.40 26.40 26.40 26.40
pankaj prasoon - - - - 2.07
sharad kanayalal shah 1.08 1.08 1.08 1.08 1.08
thermo pads private limit... - 1.15 1.61 1.15 -

Ratings & Research Reports

Company Presentations

Company News

Prevest Denpro - Quaterly Results 11 Nov, 5:29 PM Prevest Denpro - Quaterly Results 11 Nov, 5:29 PM Prevest Denpro informs about certificate 19 Oct, 3:30 PM Prevest Denpro - Quaterly Results 8 Aug, 4:54 PM Prevest Denpro - Quaterly Results 8 Aug, 4:54 PM Prevest Denpro - Quaterly Results 8 Aug, 4:54 PM Prevest Denpro informs about audio recording of earning call 1 Jun, 12:33 PM Prevest Denpro - Quaterly Results 28 May, 4:50 PM Prevest Denpro - Quaterly Results 28 May, 4:50 PM Prevest Denpro - Quaterly Results 3 Feb, 5:48 PM Prevest Denpro - Quaterly Results 3 Feb, 5:48 PM Prevest Denpro - Quaterly Results 3 Feb, 5:48 PM Prevest Denpro informs about press release 23 Nov, 12:51 PM Prevest Denpro launches oral care product segment ‘Oradox’ 23 Nov, 10:46 AM Prevest Denpro informs about audio recording of earning call 10 Nov, 12:11 PM Prevest Denpro - Quaterly Results 3 Nov, 5:28 PM Prevest Denpro - Quaterly Results 3 Nov, 5:28 PM Prevest Denpro informs about compliance certificate 16 Oct, 5:24 PM Prevest Denpro informs about voting results of AGM and scrutinizer's report 1 Sep, 10:05 AM Prevest Denpro informs about investor presentation 8 Aug, 10:51 AM Prevest Denpro - Quaterly Results 3 Aug, 3:20 AM Prevest Denpro - Quaterly Results 3 Aug, 3:20 AM Prevest Denpro - Quaterly Results 3 Aug, 3:20 AM Prevest Denpro launches latest oral care product line ‘Oradox’ 31 Jul, 3:30 PM Prevest Denpro signs MoU with Sri Vishnu Educational Society 31 Jul, 2:58 PM Prevest Denpro informs about trading window closure 1 Jul, 11:05 AM Prevest Denpro incorporates wholly owned subsidiary 22 May, 2:57 PM Prevest Denpro informs about disclosure 16 May, 12:00 PM Prevest Denpro informs about press release 8 May, 4:55 PM Prevest Denpro informs about investor presentation 8 May, 11:26 AM Prevest Denpro - Quaterly Results 27 Apr, 2:25 PM Prevest Denpro - Quaterly Results 27 Apr, 2:25 PM Prevest Denpro - Quaterly Results 27 Apr, 2:25 PM Prevest Denpro - Quaterly Results 13 Feb, 1:04 PM Prevest Denpro - Quaterly Results 13 Feb, 1:04 PM Prevest Denpro - Quaterly Results 13 Feb, 1:04 PM Prevest Denpro informs about trading window closure 29 Dec, 3:12 PM Prevest Denpro informs about disclosures 26 Dec, 12:48 PM Prevest Denpro informs about disclosure 26 Dec, 12:27 PM Prevest Denpro informs about board meeting 3 Nov, 4:10 PM Prevest DenPro opens R&D and Testing Center adjoining to Jammu factory 3 Nov, 9:18 AM Prevest Denpro informs about proceedings of AGM 17 Sep, 12:16 PM Prevest Denpro informs about appointment of CS and CO 29 Aug, 12:06 PM Prevest Denpro informs about press release 22 Aug, 3:05 PM Prevest Denpro submits investor presentation 11 Aug, 9:42 AM Prevest Denpro informs about press release 11 Aug, 9:42 AM Prevest Denpro signs MoU with Central University Jammu 30 May, 11:29 AM Prevest DenPro gets USFDA clearance for Dental Cavity Liners 17 May, 10:53 AM Prevest Denpro informs about outcome of board meeting 8 Nov, 4:50 PM Prevest Denpro coming with an IPO to raise upto Rs 27 crore 14 Sep, 2:09 PM

Prevest Denpro Stock Price Analysis and Quick Research Report. Is Prevest Denpro an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. Prevest Denpro stock price today is Rs 540.25. So, let’s look into Prevest Denpro and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 11.4924 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Prevest Denpro has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Prevest Denpro , the EPS growth was 2.6328 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Prevest Denpro has OPM of 35.5082760746849 % which is a good sign for profitability.
     
  • ROE: Prevest Denpro have a average ROE of 19.9796 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Prevest Denpro is Rs 540.25. One can use valuation calculators of ticker to know if Prevest Denpro share price is undervalued or overvalued.
Last Updated on:
Brief about Prevest Denpro
X